Weiyang Lu

Prof. Weiyang Lu

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PBPaul Bansal
Paul Bansal
SWShuanglian Wang
Shuanglian Wang
SLShenghao Liu
Shenghao Liu
YXYun-Yan Xiang
Yun-Yan Xiang
WLWeiyang Lu
Weiyang Lu
QWQinghua Wang
Qinghua Wang
Pancreatic islet β-cells produce large amounts of γ-aminobutyric acid (GABA), which is co-released with insulin. GABA inhibits glucagon secretion by hyperpolarizing α-cells via type-A GABA receptors (GABAARs). We and others recently reported that islet β-cells also express GABAARs and that activation of GABAARs increases insulin release. Here we investigate the effects of insulin on the GABA-GABAAR system in the pancreatic INS-1 cells using perforated-patch recording. The results showed that GABA produces a rapid inward current and depolarizes INS-1 cells. However, pre-treatment of the cell with regular insulin (1 µM) suppressed the GABA-induced current (IGABA) by 43%. Zinc-free insulin also suppressed IGABA to the same extent of inhibition by regular insulin. The inhibition of IGABA occurs within 30 seconds after application of insulin. The insulin-induced inhibition of IGABA persisted in the presence of PI3-kinase inhibitor, but was abolished upon inhibition of ERK, indicating that insulin suppresses GABAARs through a mechanism that involves ERK activation. Radioimmunoassay revealed that the secretion of C-peptide was enhanced by GABA, which was blocked by pre-incubating the cells with picrotoxin (50 µM, p<0.01) and insulin (1 µM, p<0.01), respectively. Together, these data suggest that autocrine GABA, via activation of GABAARs, depolarizes the pancreatic β-cells and enhances insulin secretion. On the other hand, insulin down-regulates GABA-GABAAR signaling presenting a feedback mechanism for fine-tuning β-cell secretion.

9 March 2017 in Diabetologia
Verified
Journal Article
Closed access
PDF file
AFAllen L. Feng
Allen L. Feng
YXYun-Yan Xiang
Yun-Yan Xiang
LGLe Gui
Le Gui
GKGesthika Kaltsidis
Gesthika Kaltsidis
Qingping FengQingping Feng
Qingping Feng
WLWeiyang Lu
Weiyang Lu

1 March 2017 in American Journal of Physiology-Gastrointestinal and Liver Physiology
Verified
Journal Article
Closed access
PDF file
SWShuanglian Wang
Shuanglian Wang
YXYun-Yan Xiang
Yun-Yan Xiang
JZJianchun Zhu
Jianchun Zhu
FYFan Yi
Fan Yi
JLJingxin Li
Jingxin Li
WLWeiyang Lu
Weiyang Lu
γ-Aminobutyric acid (GABA) is produced by various cells through the catalytic activity of glutamic acid decarboxylase (GAD). Activation of type-A GABA receptor (GABAAR) inhibits stem cell proliferation but protects differentiated cells from injures. The present study investigated hepatic GABA signaling system and the role of this system in liver physiology and pathophysiology. RT-PCR and immunoblot assays identified GAD and GABAAR subunits in rat livers and in HepG2 and Clone 9 hepatocytes. Patch-clamp recording detected GABA-induced currents in Clone 9 hepatocytes and depolarization in WITT cholangiocytes. The function of hepatic GABA signaling system in rats was examined using models of d-galactosamine (GalN)-induced acute hepatocytic injury in vivo and in vitro. The expression of GAD increased whereas GABAAR subunits decreased in the liver of GalN-treated rats. Remarkably, treating rats with GABA or the GABAAR agonist muscimol, but not the GABABR agonist baclofen, protected hepatocytes against GalN toxicity and improved liver function. In addition, muscimol treatment decreased the formation of pseudobile ductules and the enlargement of hepatocytic canaliculi in GalN-treated rats. Our results revealed that a complex GABA signaling system exists in the rat liver. Activation of this intrahepatic GABAergic system protected the liver against toxic injury.NEW & NOTEWORTHY Auto- and paracrine GABAergic signaling systems exist in the rat hepatocytes and cholangiocytes. Activation of GABA signaling protects liver function from d-galactosamine injury by reducing toxic impairment of hepatocytes and by decreasing cholangiocyte proliferation.

27 August 2019 in Glia
Verified
Journal Article
Closed access
PDF file
MMMatthew J. E. Maksoud
Matthew J. E. Maksoud
VTVasiliki Tellios
Vasiliki Tellios
DADong An
Dong An
YXYun‐Yan Xiang
Yun‐Yan Xiang
WLWeiyang Lu
Weiyang Lu

1 October 2018 in Cellular Immunology
Verified
Journal Article
Closed access
LJLuan Januzi
Luan Januzi
JPJacob W. Poirier
Jacob W. Poirier
MMMatthew J.E. Maksoud
Matthew J.E. Maksoud
YXYun-Yan Xiang
Yun-Yan Xiang
RVRudolf A.W. Veldhuizen
Rudolf A.W. Veldhuizen
WLWeiyang Lu
Weiyang Lu

23 July 2010 in Experimental Mechanics
Verified
Journal Article
Closed access
PDF file
WLWeiyang Lu
Weiyang Lu
BSB. Song
B. Song